Opdivo

Discussion in 'Bristol-Myers Squibb' started by anonymous, Jun 18, 2019 at 10:16 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

     

  2. anonymous

    anonymous Guest

    Opdivo according to Cavario is doing better than Keytruda. HAHAHA!!!
     
  3. anonymous

    anonymous Guest

    Remember when Tom compared Opdivo and Keytruda to Pepsi and Coke? It’s very true, Keytruda is Coke and just like Coke dominating market share. Opdivo is Pepsi and barely holding on.
     
  4. anonymous

    anonymous Guest

    How is holding on at all? The moron pod in my area works a total of about 2 hours per week, which probably consists of sitting around talking to each other. It’s pathetic to sell a drug at prices that bankrupt sick people who are dying and pay a salary to a bunch of thieves.
     
  5. anonymous

    anonymous Guest

    That’s Pharma! Greedy fucks!
     
  6. anonymous

    anonymous Guest

    Cavario is an idiot. He got bested by Merck when BMS held all the cards. Greed to get all pt comers instead of methodically acquiring more and more indications cost Opdivo the leadership to Keytruda Merck is laughing all the way to the bank Check out the stock and how the tw companies have performed. Celgene has been a disappointment but then again Cavario made the call. Merck i# rocking because of Cavario
     
  7. anonymous

    anonymous Guest

    Bro...at least get his name right. Damn.
     
  8. anonymous

    anonymous Guest

    Any sales rep whose numbers performed the way our stock price has over the past few years would be fired. So why is the CEO secure in his job?
     
  9. anonymous

    anonymous Guest

    Your sales reps perform?
     
  10. anonymous

    anonymous Guest

    Bristol Myers has a long and ugly history of screwing things up. Capoten vs. Vesotec; Venlev; Pravachol Prove-It trial; to name a few

    Caforio’s performance compensation should be judged 100% based on share price growth - if ours is based on market share growth.
     
  11. anonymous

    anonymous Guest

    You guys are all freaking dumbasses. His performance compensation should be based on revenue, just like everyone else’s. Company had the best revenue year EVER last year. And we all saw that reflected in our compensation. So just shut the fuck up and stop whining already. Goddamn.
     
  12. anonymous

    anonymous Guest

    So, everyone hit the top of plan? Everyone who “sells” Opdivo?
     
  13. anonymous

    anonymous Guest

    It’s easy to perform and increase in sales dollars when you increase the price of the drug......or maybe it was that lunch you just dumped.
     
  14. anonymous

    anonymous Guest

    Don't field reps get the "company" factor the same as everyone else? Company factor = Giovanni. If you got the company factor then stop bitching. If not, then go ahead and bitch.
     
  15. anonymous

    anonymous Guest

    Here's some good news
    Opdiva



     
  16. anonymous

    anonymous Guest

    Looks like stock rebounded pretty fucking nicely.
     
  17. anonymous

    anonymous Guest

    Profanity not needed!